本研究采用超临界反溶剂流化(SAS-FB) 包衣技术，将难溶性药物他达拉非包覆在微晶纤维素(MCC) 微丸表面制备速释微丸，并与超临界反溶剂(SAS) 法和流化床(FB) 法所得制品进行表面形态和体外溶出度的对比。SAS-FB 法制得微丸的扫描电镜照片显示，他达拉非以针状结晶均匀地包裹在MCC 微丸表面，而FB 法制得微丸中他达拉非则以块状结晶包覆在MCC 微丸表面，SAS 法制备的他达拉非外观形态与原料药相似，以细条状互相聚集在一起。与其他2 种方法所得制品相比，SAS-FB 法制备的微丸药物溶出速度更快、程度更高。通过加入表面活性剂十二烷基硫酸钠或聚乙烯吡咯烷酮对MCC 微丸进行表面改性，可进一步提高他达拉非的溶出速度和溶出量。本研究表明，SAS-FB 法可一步制备他达拉非微丸，在提高难溶性药物溶出度的方面具有应用潜力。
Abstract
Insoluble drug tadalafil was coated on microcrystalline cellulose(MCC) pellet cores to prepare immediate-release pellets by supercritical anti-solvent fluidization(SAS-FB) coating technology in this paper. The morphology and in vitro dissolution of the pellets were compared with those of tadalafil treated with the supercritical antisolvent(SAS) and the pellets prepared by fluidized bed(FB)coating. The scanning electron micrographs of the pellets prepared by SAS-FB showed that tadalafil was uniformly distributed on the surface of the MCC pellet cores in the form of thin strips, while the pellets produced by FB were coated with bulk crystalline tadalafil. The shape of tadalafil treated with SAS was similar to the bulk drug, clustered in thin strips. Comparing with the other two methods, the pellets prepared by SAS-FB had faster in vitro dissolution rate and higher dissolved percentage. By surface modification of MCC cores with sodium dodecyl sulfate or polyvinylpyrrolidone, the dissolution rate and dissolved percentage of tadalafil pellets prepared by SAS-FB could be further improved. This study showed that the SAS-FB could prepare tadalafil pellets in one step, which had the potential to improve the dissolution of poorly soluble drugs.
关键词
他达拉非 /
微丸 /
超临界反溶剂流化过程 /
超临界反溶剂 /
流化床 /
包衣
{{custom_keyword}} /
Key words
tadalafil /
pellet /
supercritical antisolvent fluidized bed process /
supercritical antisolvent /
fluidized bed /
coating
{{custom_keyword}} /
{{custom_sec.title}}
{{custom_sec.title}}
{{custom_sec.content}}
参考文献
[1] 刘学武, 李志义, 韩 冰, 等．超临界反溶剂过程制备槲皮素超细颗粒[J]．中国化学工程学报, 2005, 13(1): 128-130．
[2] REVERCHON E, DE MARCO I, ADAMI R, et al．Expanded micro-particles by supercritical antisolvent precipitation: interpretation of results [J]．J Supercrit Fluids, 2008, 44(1): 98-108．
[3] 李淑芬, 吴希文, 侯彩霞, 等．超临界流体技术开发应用现状和前景展望[J]．现代化工, 2007, 27(2): 1-7．
[4] REVERCHON E, ADAMI R, CAPUTO G, et al．Spherical microparticles production by supercritical antisolvent precipitation: Interpretation of results [J]．J Supercrit Fluids, 2008, 47(1): 70-84．
[5] REVERCHON E．Supercritical antisolvent precipitation of micro- and nano-particles [J]．J Supercrit Fluids, 1999,15(1): 1-21．
[6] 游国叶．流化床包衣法制备氢氯噻嗪缓释微丸[J]．河南大学学报: 医学版, 2018, 37(3): 166-169．
[7] 单 利, 史 焱, 王玉丽, 等．基于流化床包衣工艺的伊曲康唑速释微丸的制备和评价研究[J]．中国药学杂志, 2013,48(1): 54-58．
[8] LI Q, HUANG D, LU T, et al．Supercritical fluid coating of API on excipient enhances drug release [J]．Chem Eng J,
2017, 313: 317-327．
[9] MATOS R L, LU T, MCCONVILLE C, et al．Analysis of curcumin precipitation and coating on lactose by the integrated supercritical antisolvent-fluidized bed process[J]．J Supercrit Fluids, 2018, 141: 143-156．
[10] 郑 瀚, 许永德, 孙吉磊, 等．他达拉非5 mg治疗前列腺增生继发下尿路症状的荟萃分析[J]．中华老年多器官疾病杂志, 2020, 19(2): 119-126．
[11] 陈小云, 秦 燕, 肖 峰, 等．他达拉非口腔速溶膜的临床前药动学研究[J]．中国新药杂志, 2019, 28(17): 2157-2162．．
[12] 黄德恩．基于高熔点难溶性药物制备固体分散体及药动学研究[D]．广州: 广州中医药大学硕士学位论文,2017．
{{custom_fnGroup.title_cn}}
脚注
{{custom_fn.content}}
PDF(2206 KB)
